PROFUND ADVISORS LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 319 filers reported holding GW PHARMACEUTICALS PLC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.2%.

Quarter-by-quarter ownership
PROFUND ADVISORS LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$421,000
+94.9%
1,942
+3.7%
0.02%
+77.8%
Q4 2020$216,000
-30.1%
1,872
-41.0%
0.01%
-43.8%
Q3 2020$309,000
-33.1%
3,173
-15.7%
0.02%
-38.5%
Q2 2020$462,000
+71.1%
3,766
+22.2%
0.03%
+30.0%
Q1 2020$270,000
-35.9%
3,081
-23.4%
0.02%
+11.1%
Q4 2019$421,000
-3.0%
4,022
+6.5%
0.02%
-18.2%
Q3 2019$434,000
-41.2%
3,777
-11.7%
0.02%
-37.1%
Q2 2019$738,000
+3.7%
4,279
+1.4%
0.04%
+2.9%
Q1 2019$712,000
+107.0%
4,221
+19.5%
0.03%
+61.9%
Q4 2018$344,0003,5320.02%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders